{"id":"https://openalex.org/W3120777650","doi":"https://doi.org/10.1093/ofid/ofaa439.073","title":"28. Immunogenicity of rVSV\u0394G-ZEBOV-GP Ebola Vaccine (ERVEBO\u2122) in Participants by Age, Sex, and Baseline GP-ELISA Titer: A Post Hoc Analysis of Three Phase 2/3 Trials","display_name":"28. Immunogenicity of rVSV\u0394G-ZEBOV-GP Ebola Vaccine (ERVEBO\u2122) in Participants by Age, Sex, and Baseline GP-ELISA Titer: A Post Hoc Analysis of Three Phase 2/3 Trials","publication_year":2020,"publication_date":"2020-10-01","ids":{"openalex":"https://openalex.org/W3120777650","doi":"https://doi.org/10.1093/ofid/ofaa439.073","mag":"3120777650","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7776050"},"language":"en","primary_location":{"id":"doi:10.1093/ofid/ofaa439.073","doi":"https://doi.org/10.1093/ofid/ofaa439.073","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofaa439.073","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1093/ofid/ofaa439.073","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065532410","display_name":"Jakub K. Simon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jakub Simon","raw_affiliation_strings":["Merck & Co., Inc., Kenilworth, NJ, USA, Kenilworth, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth, NJ, USA, Kenilworth, New Jersey","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064321842","display_name":"Stephen B. Kennedy","orcid":"https://orcid.org/0000-0002-0318-930X","observed_orcids":["https://orcid.org/0000-0002-0318-930X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen Kennedy","raw_affiliation_strings":["Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Montserrado, Liberia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Montserrado, Liberia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113571171","display_name":"Barbara E. Mahon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289490764","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12","country_code":"US","type":"government","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barbara Mahon","raw_affiliation_strings":["Centers for Disease Control and Prevention, Atlanta, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centers for Disease Control and Prevention, Atlanta, Georgia","institution_ids":["https://openalex.org/I1289490764"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059368929","display_name":"Sheri A. Dubey","orcid":"https://orcid.org/0000-0002-0712-9865","observed_orcids":["https://orcid.org/0000-0002-0712-9865"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sheri Dubey","raw_affiliation_strings":["Merck & Co., Inc., Kenilworth, NJ, USA, Kenilworth, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth, NJ, USA, Kenilworth, New Jersey","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031908285","display_name":"Rebecca J. Grant-Klein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rebecca Grant-Klein","raw_affiliation_strings":["Merck & Co., Inc., Kenilworth, NJ, USA, Kenilworth, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth, NJ, USA, Kenilworth, New Jersey","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103405156","display_name":"Ken Liu","orcid":"https://orcid.org/0009-0004-5439-9448","observed_orcids":["https://orcid.org/0009-0004-5439-9448"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ken Liu","raw_affiliation_strings":["Merck & Co., Inc., Kenilworth, NJ, USA, Kenilworth, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth, NJ, USA, Kenilworth, New Jersey","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108419618","display_name":"Jonathan S. Hartzel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan Hartzel","raw_affiliation_strings":["Merck & Co., Inc., Kenilworth, NJ, USA, Kenilworth, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth, NJ, USA, Kenilworth, New Jersey","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075394578","display_name":"Beth-Ann Coller","orcid":"https://orcid.org/0000-0001-6006-1073","observed_orcids":["https://orcid.org/0000-0001-6006-1073"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Beth-Ann Coller","raw_affiliation_strings":["Merck & Co., Inc., Kenilworth, NJ, USA, Kenilworth, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth, NJ, USA, Kenilworth, New Jersey","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014648197","display_name":"Carolee Welebob","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carolee Welebob","raw_affiliation_strings":["Merck & Co., Inc., Kenilworth, NJ, USA, Kenilworth, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth, NJ, USA, Kenilworth, New Jersey","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077955682","display_name":"Mary Elizabeth Hanson","orcid":"https://orcid.org/0000-0003-4785-7207","observed_orcids":["https://orcid.org/0000-0003-4785-7207"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary Hanson","raw_affiliation_strings":["Merck & Co., Inc., Kenilworth, NJ, USA, Kenilworth, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth, NJ, USA, Kenilworth, New Jersey","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046960097","display_name":"Rebecca F. Grais","orcid":"https://orcid.org/0000-0002-5037-8218","observed_orcids":["https://orcid.org/0000-0002-5037-8218"]},"institutions":[{"id":"https://openalex.org/I4387152612","display_name":"Epicentre","ror":"https://ror.org/034w22c34","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210128224","https://openalex.org/I4387152612"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Rebecca Grais","raw_affiliation_strings":["Epicentre, Paris, Centre, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epicentre, Paris, Centre, France","institution_ids":["https://openalex.org/I4387152612"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4053,"currency":"USD","value_usd":4053},"apc_paid":{"value":4053,"currency":"USD","value_usd":4053},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"7","issue":"Supplement_1","first_page":"S38","last_page":"S38"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11581","display_name":"Viral Infections and Outbreaks Research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11581","display_name":"Viral Infections and Outbreaks Research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12047","display_name":"Viral Infections and Vectors","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11135","display_name":"Virology and Viral Diseases","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ebola-virus-disease","display_name":"Ebola virus disease","score":0.625},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.7360000014305115},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.6850000023841858},{"id":"https://openalex.org/keywords/igg-response","display_name":"IgG antibody response","score":0.9350000023841858},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":0.8659999966621399},{"id":"https://openalex.org/keywords/age-differences","display_name":"age differences","score":0.9070000052452087},{"id":"https://openalex.org/keywords/vaccine-safety","display_name":"vaccine safety","score":0.37599998712539673},{"id":"https://openalex.org/keywords/plaque-reduction-neutralization-test","display_name":"plaque reduction neutralization test","score":0.5630000233650208}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8258973956108093},{"id":"https://openalex.org/C138894074","wikidata":"https://www.wikidata.org/wiki/Q7201694","display_name":"Plaque reduction neutralization test","level":4,"score":0.7467698454856873},{"id":"https://openalex.org/C2777469322","wikidata":"https://www.wikidata.org/wiki/Q8064876","display_name":"Ebola virus","level":3,"score":0.7129760980606079},{"id":"https://openalex.org/C3018567284","wikidata":"https://www.wikidata.org/wiki/Q1044","display_name":"Sierra leone","level":2,"score":0.7069196701049805},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.6920046806335449},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6152743101119995},{"id":"https://openalex.org/C2778933410","wikidata":"https://www.wikidata.org/wiki/Q3553092","display_name":"Ebola vaccine","level":4,"score":0.6077995896339417},{"id":"https://openalex.org/C32611913","wikidata":"https://www.wikidata.org/wiki/Q2166189","display_name":"Titer","level":3,"score":0.577860414981842},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5618786215782166},{"id":"https://openalex.org/C116675565","wikidata":"https://www.wikidata.org/wiki/Q3241045","display_name":"Outbreak","level":2,"score":0.41863495111465454},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4170219898223877},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3520508110523224},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.22251349687576294},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C47768531","wikidata":"https://www.wikidata.org/wiki/Q1127188","display_name":"Development economics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1093/ofid/ofaa439.073","doi":"https://doi.org/10.1093/ofid/ofaa439.073","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofaa439.073","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7776050","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7776050/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7776050/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infect Dis","raw_type":"Text"},{"id":"pmh:oai:europepmc.org:6697050","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC7776050","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/ofid/ofaa439.073","doi":"https://doi.org/10.1093/ofid/ofaa439.073","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofaa439.073","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3120777650.pdf","grobid_xml":"https://content.openalex.org/works/W3120777650.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4301603384","https://openalex.org/W4210708701","https://openalex.org/W3128537626","https://openalex.org/W2763440465","https://openalex.org/W4388737362","https://openalex.org/W3034092089","https://openalex.org/W2625662684","https://openalex.org/W7165873997","https://openalex.org/W2624564619","https://openalex.org/W4403202763"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"The":[2,149,176,295],"recent":[3],"Ebola":[4],"virus":[5,38],"disease":[6],"(EVD)":[7],"outbreak":[8,107],"in":[9,47,64,79,93,116,216,285,300,312],"the":[10,14,17,42,50,103,119,156,186,194,212],"Democratic":[11],"Republic":[12],"of":[13,20,49,118,288,330,350,372,392,412,432,452,472,492,512,532],"Congo":[15],"highlights":[16],"sustained":[18],"threat":[19],"EVD":[21,71],"morbidity":[22],"and":[23,27,72,99,122,136,188,207,215,220,234,244,246,277,302],"mortality":[24],"where":[25],"healthcare":[26],"vaccine":[28,40],"delivery":[29],"are":[30,307],"challenging.":[31],"ERVEBO\u00ae,":[32],"a":[33,113,124,263,275,328,348,370,390,410,430,450,470,490,510,530],"live":[34],"recombinant":[35],"vesicular":[36],"stomatitis":[37],"(VSV)":[39],"containing":[41],"Zaire":[43],"ebolavirus":[44],"glycoprotein":[45],"(GP)":[46],"place":[48],"VSV":[51],"GP":[52],"(rVSV\u0394G-ZEBOV-GP),":[53],"was":[54],"developed":[55],"by":[56,128,185,193],"Merck":[57,323,331,343,351,365,373,385,393,405,413,425,433,445,453,465,473,485,493,505,513,525,533],"&":[58,133,146,254,325,332,345,352,367,374,387,394,407,414,427,434,447,454,467,474,487,494,507,514,527,534],"Co.,":[59,333,353,375,395,415,435,455,475,495,515,535],"Inc.,":[60,334,354,376,396,416,436,456,476,496,516,536],"Kenilworth,":[61,335,355,377,397,417,437,457,477,497,517,537],"NJ,":[62,336,356,378,398,418,438,458,478,498,518,538],"USA":[63,337,357,379,399,419,439,459,479,499,519,539],"collaboration":[65],"with":[66,163,228,249,304,309],"multiple":[67],"partners":[68],"to":[69,108,200,261,282],"prevent":[70],"has":[73],"been":[74],"approved":[75],"for":[76,315],"human":[77],"use":[78],"several":[80],"countries.":[81],"Methods":[82],"We":[83],"pooled":[84],"data":[85,165,270],"from":[86,172,226],"three":[87,120,174],"Phase":[88],"2/3":[89],"clinical":[90],"trials":[91],"conducted":[92],"Guinea":[94],"(FLW),":[95],"Sierra":[96],"Leone":[97],"(STRIVE),":[98],"Liberia":[100],"(PREVAIL)":[101],"during":[102],"2013\u20132016":[104],"West":[105],"African":[106],"assess":[109],"immune":[110,279,297],"responses":[111,298],"using":[112],"validated":[114],"assay":[115,141],"each":[117],"studies":[121],"performed":[123],"post":[125],"hoc":[126],"analysis":[127,151],"sex,":[129,290],"age":[130,266],"(18\u201350":[131],"yrs":[132],">50":[134],"yrs)":[135],"baseline":[137],"(BL)":[138],"GP-enzyme-linked":[139],"immunosorbent":[140],"(ELISA)":[142],"titer":[143],"(<":[144],"200":[145,253],"\u2265200":[147,255],"EU/ml).":[148],"full":[150],"set":[152],"(FAS)":[153],"population":[154,214],"included":[155],"primary":[157],"immunogenicity":[158],"populations":[159],"(all":[160],"vaccinated":[161],"participants":[162,248,286,303],"serology":[164],"collected":[166],"within":[167],"an":[168],"acceptable":[169],"day":[170],"range)":[171],"all":[173,217],"trials.":[175],"endpoints":[177],"were":[178,240],"total":[179],"IgG":[180],"antibody":[181,190],"response":[182,191,280],"(EU/mL)":[183],"measured":[184,192],"GP-ELISA":[187,219,251,293],"neutralizing":[189],"plaque":[195],"reduction":[196],"neutralization":[197],"test":[198],"(PRNT)":[199],"rVSV\u0394G-ZEBOV-GP":[201,273],"at":[202,231],"Days":[203],"14,":[204],"28,":[205],"180,":[206],"365":[208],"postvaccination.":[209],"Results":[210],"In":[211],"overall":[213],"subgroups,":[218],"PRNT":[221],"geometric":[222],"mean":[223],"titers":[224],"increased":[225],"BL,":[227],"most":[229],"peaking":[230],"Day":[232,237],"28":[233],"persisting":[235],"through":[236],"365.":[238],"There":[239,257],"differences":[241],"between":[242,247,265],"males":[243],"females":[245,301],"BL":[250,292],"<":[252],"EU/ml.":[256],"did":[258],"not":[259],"appear":[260],"be":[262],"difference":[264],"groups.":[267],"Conclusion":[268],"These":[269],"demonstrate":[271],"that":[272],"elicits":[274],"robust":[276],"durable":[278],"up":[281],"12":[283],"months":[284],"regardless":[287],"age,":[289],"or":[291],"titer.":[294],"higher":[296],"observed":[299],"preexisting":[305],"immunity":[306],"consistent":[308],"those":[310],"described":[311],"published":[313],"literature":[314],"other":[316],"vaccines.":[317],"Disclosures":[318],"Jakub":[319],"Simon,":[320],"MD,":[321,342,364],"MS,":[322,384],"Sharp":[324,344,366,386,406,426,446,466,486,506,526],"Dohme":[326,346,368,388,408,428,448,468,488,508,528],"Corp,":[327],"subsidiary":[329,349,371,391,411,431,451,471,491,511,531],"(Employee,":[338,380,400,420,440,460,480,500,520],"Shareholder)":[339,381,401,421,441,461,481,501,521],"Stephen":[340],"Kennedy,":[341],"Corp.,":[347,369,389,409,429,449,469,489,509,529],"(Scientific":[358,540],"Research":[359,541],"Study":[360,542],"Investigator)":[361,543],"Barbara":[362],"Mahon,":[363],"Sheri":[382],"Dubey,":[383],"Rebecca":[402,522],"Grant-Klein,":[403],"PhD,":[404,424,444,464,484,504,524],"Ken":[422],"Liu,":[423],"Jonathan":[442],"Hartzel,":[443],"Beth-Ann":[462],"Coller,":[463],"Carolee":[482],"Welebob,":[483],"Mary":[502],"Hanson,":[503],"Grais,":[523]},"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2021-01-18T00:00:00"}